SOX11 augments BCR signaling to drive MCL-like tumor development

Authors

• Kuo, Pei-Yu¹
• Jatiani, Shashidhar S.²
• Rahman, Adeeb H.^{3, 4}
• Edwards, Donna¹
• Jiang, Zewei¹
• Ahr, Katya¹
• Perumal, Deepak¹
• Leshchenko, Violetta V.¹
• Brody, Joshua¹
• Shaknovich, Rita⁵
• Ye, B. Hilda⁶
• Parekh, Samir¹

• ¹ Hematology and Medical Oncology,
• ² Department of Pharmacological Sciences,
• ³ Human Immune Monitoring Core, and
• ⁴ Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY;
• ⁵ Division of Hematology/Oncology, Weill Cornell Medical College, New York, NY; and
• ⁶ Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY

Type

Published Article

Journal

Blood

Publisher

American Society of Hematology

Publication Date

May 17, 2018

Volume

131

Issue

20

Pages

2247–2255

Identifiers

DOI: 10.1182/blood-2018-02-832535

PMID: 29615403

PMCID: PMC5958658

Source

PubMed Central

License

Unknown